Biokin Pharmaceutical is a chemical drug and biological drug-based company.
Business Model:
Revenue: $0
Employees: 1,001-5,000
Address:
City: Chengdu
State: Sichuan
Zip:
Country: China
Biokin Pharmaceutical integrates drug research and development, production, and marketing. They offer a frontier field of global biomedicine, based on solving unmet clinical needs, with the ability to research and develop a full range of drugs, including small molecule chemical drugs, macromolecular biological drugs, and ADC drugs.
Contact Phone:
Contact Email:
Listed Exchange:
SSE
IPO Date:
12/26/2022
IPO Valuation:
$1B
Ticker Symbol:
688506
IPO Price:
$3.5477291660681964/share
Amount Raised:
$142M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2011 | Angel Round | 2 | $465.4k |
Rongxi Venture Xinjiang Xinxi Guquan Touzi Rongxi Venture Xinjiang Xinxi Guquan Touzi |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|